Microbiome Therapeutics for Intractable Diseases
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
53
NCT05975047
A Study of LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC)
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 24, 2023
Completion: Mar 5, 2024
NCT06749795
LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis (UC)
Start: Mar 24, 2025
Completion: Mar 24, 2026
Loading map...